Literature DB >> 4054891

Segmental subepithelial deposits in primary glomerulonephritis: scanning electron microscopic examination of acellular glomeruli.

S M Bonsib.   

Abstract

More accurate perception of the structural alterations in glomerular basement membrane (GBM) produced by subepithelial immune complex deposits is possible with a recently adapted technique that uses scanning electron microscopy of acellular material. With this procedure frozen tissue is treated sequentially by osmotic lysis, detergents, and DNase to solubilize both cellular components and immune complex deposits. Four patients with glomerulonephritis (acute postinfectious glomerulonephritis [one patient], segmental membranous glomerulonephritis [two patients], membranoproliferative glomerulonephritis, type III [one patient]) in whom segmental subepithelial deposits were found were studied by this technique; the resulting observations were correlated with the results of routine morphologic studies and a previous study of minimal change disease and diffuse membranous glomerulonephritis. Four types of structural alterations of the subepithelial GBM surface were observed. The differences in lesions observed in the various forms of glomerulonephritis are believed to be related to temporal, quantitative, and qualitative differences in immune complex-mediated glomerular injury.

Entities:  

Mesh:

Year:  1985        PMID: 4054891     DOI: 10.1016/s0046-8177(85)80179-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  2 in total

1.  Three-dimensional studies of acellular glomerular basement membranes in dense-deposit disease.

Authors:  N Weidner; W B Lorentz
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

2.  Scanning electron microscopy of cellular and acellular glomeruli of male dogs affected with Samoyed hereditary glomerulopathy and a carrier female.

Authors:  B S Jansen; V E Valli; P S Thorner; R Baumal
Journal:  Can J Vet Res       Date:  1987-10       Impact factor: 1.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.